Familial hypercholesterolemia: Experience from France

Current Opinion in Lipidology

Volumn 29, Issue 2, 2018, Pages 65-71

  Rabès, Jean Pierre ^a,b,c   Béliard, Sophie ^d,e,f,g   Carrié, Alain ^h,i  

^a HÔPITAL AMBROISE PARÉ   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^c BICHAT HOSPITAL   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

^e INSERM   (France)

^f CNRS   (France)

^g ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^h PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

ⁱ SORBONNE UNIVERSITÉ   (France)

Author keywords

apolipoprotein B; cascade screening; familial hypercholesterolemia; French registry; gene score; LDL cholesterol; LDL Receptor; molecular diagnosis; Proprotein convertase subtilisin kexin type 9

Indexed keywords

APOLIPOPROTEIN B; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; PROPROTEIN CONVERTASE 9;

CLINICAL ASSESSMENT; COUNSELOR; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY HISTORY; FRANCE; GENE MUTATION; GENETIC COUNSELING; GENETIC SUSCEPTIBILITY; HEALTH CARE PERSONNEL; HUMAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL; MEDICAL EDUCATION; MEDICAL HISTORY; MOLECULAR DIAGNOSIS; PRIORITY JOURNAL; REVIEW; GENETIC PREDISPOSITION; GENETICS; MUTATION;

FRANCE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MUTATION;

EID: 85044235456     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0000000000000496     Document Type: Review

References (15)

1. Nordestgaard BG, Chapman MJ, Humphries SE,. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: Guidance for clinicians to prevent coronary heart disease: Consensus statement of the European Atherosclerosis Society. Eur Heart J 2013; 34: 3478-3490a.
2. Farnier M, Bruckert E, Boileau C, Krempf M,. Diagnostic and treatment of familial hypercholesterolemia (FH) in adult: Guidelines from the New French Society of Atherosclerosis (NSFA). Presse Med 2013; 42 (6 Pt 1): 930-950.
3. Carreau V, Girardet JP, Bruckert E,. Long-term follow-up of statin treatment in a cohort of children with familial hypercholesterolemia: Efficacy and tolerability. Paediatr Drugs 2011; 13: 267-275.
4. Beliard S, Millier A, Carreau V,. The very high cardiovascular risk in heterozygous familial hypercholesterolemia: Analysis of 734 French patients. J Clin Lipidol 2016; 10: 1129-1136.e3.
5. Marduel M, Carrié A, Sassolas A,. Molecular spectrum of autosomal dominant hypercholesterolemia in France. Hum Mutat 2010; 31: E1811-E1824.
6. Abifadel M, Varret M, Rabès JP,. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet 2003; 34: 154-156.
7. Andersen LH, Miserez AR, Ahmad Z, Andersen RL,. Familial defective apolipoprotein B-100: A review. J Clin Lipidol 2016; 10: 1297-1302.
8. Ferrières J, Ruidavets JB, Perret B,. Prevalence of dyslipidaemias in a representative sample of the French population. Arch Mal Coeur Vaiss 2005; 98: 127-132.
9. Taylor A, Wang D, Patel K,. Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade project. Clin Genet 2010; 77: 572-580.
10. Talmud PJ, Shah S, Whittall R,. Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: A case-control study. Lancet 2013; 381: 1293-1301.
11. Futema M, Shah S, Cooper JA,. Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries. Clin Chem 2015; 61: 231-238.
12. Lacocca MA, Hegele RA,. Recent advances in genetic testing for familial hypercholesterolemia. Expert Rev Mol Diagn 2017; 17: 641-651.
13. Wang J, Dron JS, Ban MR,. Polygenic versus monogenic causes of hypercholesterolemia ascertained clinically. Arterioscler Thromb Vasc Biol 2016; 36: 2439-2445.
14. Sharifi M, Higginson E, Bos S,. Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia. Atherosclerosis 2017; 263: 405-411.
15. Khera AV, Won HH, Peloso GM,. Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia. J Am Coll Cardiol 2016; 67: 2578-2589.